Last Updated on August 23, 2023 by The Health Master
This newly approved medication stands as the generic equivalent of Leo Pharma AS’s Protopic Ointment, 0.03%, marking a significant stride in the pharmaceutical industry.
Glenmark’s Venture into the US Market:
Glenmark’s accomplishment is complemented by its upcoming plans for the distribution of Tacrolimus Ointment, 0.03%, across the United States through its subsidiary, Glenmark Pharmaceuticals US.
This move is expected to solidify Glenmark’s presence in the US pharmaceutical landscape.
Glenmark’s ANDA approval:
Glenmark Pharmaceuticals boasts a diverse portfolio, encompassing a total of 184 products that have received authorization for distribution within the expansive US marketplace.
Additionally, the company has 51 awaiting ANDA approval from the US FDA, further reflecting Glenmark’s commitment to innovation and meeting evolving healthcare demands.
The company’s strategic approach to entering the US market through its subsidiary underscores its dedication to enhancing accessibility to crucial medications.
Furthermore, IQVIA’s data showcasing the substantial sales of Protopic Ointment, 0.03%, reinforces the market’s demand for effective treatment options.
With a wide-ranging portfolio and pending ANDA approvals, Glenmark Pharmaceuticals remains poised to contribute significantly to the healthcare landscape by catering to diverse medical requirements.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model, to rewrite and present the news / article in a unique format.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: